Guide

Pharmaceutical GMP readiness in South Korea

South Korea's Ministry of Food and Drug Safety (MFDS, formerly KFDA) regulates medicines under the Pharmaceutical Affairs Act and the Regulation on Safety of Medicinal Products. Korean GMP (KGMP) is aligned with PIC/S — MFDS became a PIC/S member in 2014 — and converges with EudraLex Vol 4. Marketing requires an authorized importer/manufacturer in Korea. Serialization of prescription drugs is mandatory through the Korea Pharmaceutical Information Service (KPIS). This guide covers the Korea-specific layer over an ICH Q10 PQS.

Start free trial Free trial, no credit card, onboard in days, not months.

Regulator and legal basis

MFDS is the competent authority; provincial offices conduct routine inspections. Pharmaceutical Affairs Act is the statutory base; the KGMP regulation aligns with PIC/S PE 009. Korea is ICH and PIC/S; MFDS publishes notices in Korean with English summaries.

Licensing, release, and serialization

Domestic manufacturers and importers require MFDS licensing. Release is by an authorized person under the QMS — no statutory QP. Serialization at saleable-unit level is mandatory for prescription drugs through KPIS, using a national identifier alongside GS1; aggregation reporting is required for supply-chain events.

Documentation and language

Submissions and labelling are in Korean; technical supporting data in English is widely accepted. SOPs at foreign sites do not need to be Korean but key inspection records are often translated for MFDS inspectors.

Inspection style and common findings

MFDS inspections follow PIC/S structure with critical/major/other classifications. Common findings: data integrity, Annex 1 contamination control, validation lifecycle, and supplier qualification. MFDS is increasingly aligned with PIC/S peers and routinely shares inspection intelligence.

A 90–180 day South Korea readiness path

Days 0–30: identify Korean MAH/importer; map products and confirm KPIS onboarding. Days 31–90: align KGMP documentation; prepare Korean labelling. Days 91–180: pre-inspection readiness with PIC/S-style evidence packs; host MFDS inspection.

Standards covered in this guide

Each standard, retailer code or assurance scheme referenced above has its own deep-dive page with scope, audit detail and common pitfalls.

EU Annex 11

Annex 11 defines how GMP computerized systems must be validated, controlled, and monitored to protect product quality and patient safety across the EU, with strong data integrity and lifecycle expectations.

EU GMP Annex 1 Sterile

Annex 1 sets the modern, risk-based standard for sterile manufacturing, requiring a holistic contamination control strategy, robust aseptic operations, and documented evidence that facilities and processes consistently protect patients.

Where this lives in V5 Ultimate

The clauses above aren't theoretical — every one maps to a shipped module and an industry profile. Jump to the parts of the product that turn this guide into evidence on a Monday morning.

Modules that do the work

Document control

Versioned SOPs, controlled artwork, periodic review with e-signatures.

QMS

CAPA, deviations, change control, management review wired together.

Audits & CAPA

Findings auto-route to owners with statutory clocks and evidence trail.

Industries this hits hardest

Frequently asked

Is Korea a PIC/S member?

Yes since 2014. MFDS GMP inspections are recognized by other PIC/S members and vice versa, with reliance applied on a case-by-case basis.

How does KPIS differ from EU FMD?

Both serialize at saleable-unit level and require event reporting. KPIS uses a national identifier scheme reported to the KPIS hub; EU FMD uses a unique identifier verified at dispense via EMVS. Aggregation requirements in Korea are stricter.

Do we need a Korean QP?

No — the licensed manufacturer or importer appoints a quality manager responsible for release. The role is required by KGMP but is not a statutory QP equivalent to the EU model.

See it on your shop floor.

Free trial, no credit card, onboard in days, not months.

Start free trial See pricing →Browse all resources →